Protocol For Collecting Data On Patients With Childhood Cancer
1 other identifier
observational
30,000
1 country
1
Brief Summary
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2000
CompletedFirst Submitted
Initial submission to the registry
May 22, 2008
CompletedFirst Posted
Study publicly available on registry
May 26, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2045
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2045
April 29, 2026
April 1, 2026
44.9 years
May 22, 2008
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To provide continuing review of outcome and late toxicity for all patients actively being followed or treated for childhood cancer at St. Jude Children's Research Hospital, all St Jude Alumni and all St. Life participants.
25 years
Study Arms (1)
Observational Group
Data Collection
Interventions
Eligibility Criteria
All patients actively being treated and previously treated at St. Jude Children's Research Hospital for childhood cancer.
You may qualify if:
- All St Jude patients actively being followed or treated for childhood cancer
You may not qualify if:
- St. Jude consult only patients
- St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.
- Patients referred to St. Jude for limited care on phase 1 protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa M Hudson, MD
St. Jude Children's Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2008
First Posted
May 26, 2008
Study Start
June 8, 2000
Primary Completion (Estimated)
May 1, 2045
Study Completion (Estimated)
May 1, 2045
Last Updated
April 29, 2026
Record last verified: 2026-04